Christopher I Amos Selected Research

P-2 (P 2)

1/2017	Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study.
12/2016	Pleiotropic Analysis of Lung Cancer and Blood Triglycerides.
1/2016	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.
1/2016	Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.
4/2014	Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia.
2/2010	Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer.
6/2009	Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.
9/2007	STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher I Amos Research Topics

Disease

92	Neoplasms (Cancer) 11/2022 - 07/2002
69	Lung Neoplasms (Lung Cancer) 12/2022 - 05/2002
31	Melanoma (Melanoma, Malignant) 07/2021 - 07/2011
18	Rheumatoid Arthritis 07/2013 - 09/2002
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 07/2002
11	Adenocarcinoma of Lung 12/2022 - 05/2007
11	Carcinogenesis 01/2022 - 10/2003
9	Breast Neoplasms (Breast Cancer) 11/2022 - 05/2012
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2004
9	Adenocarcinoma 01/2019 - 02/2009
8	Inflammation (Inflammations) 01/2021 - 09/2007
7	Crohn Disease (Crohn's Disease) 11/2022 - 02/2004
7	Polyps 12/2018 - 03/2003
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2012
6	Obesity 01/2022 - 07/2013
6	Glioma (Gliomas) 07/2021 - 04/2014
5	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2013 - 04/2007
4	Squamous Cell Carcinoma of Head and Neck 11/2022 - 09/2006
4	Tobacco Use Disorder (Nicotine Dependence) 01/2021 - 06/2006
4	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2013
4	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017 - 09/2004
4	Autoimmune Diseases (Autoimmune Disease) 07/2010 - 08/2004
4	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 05/2009 - 03/2003
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 07/2005
3	Oropharyngeal Neoplasms 01/2022 - 12/2016
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 12/2017
3	Venous Thromboembolism 01/2022 - 01/2021
3	Carcinoma (Carcinomatosis) 01/2019 - 09/2003
3	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 01/2005
3	Asthma (Bronchial Asthma) 02/2016 - 07/2002
3	Disease Progression 11/2014 - 01/2005
2	Lymphoma (Lymphomas) 12/2022 - 12/2021
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 11/2017
2	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 11/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 08/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 12/2016
2	Hemorrhage 12/2021 - 01/2021
2	Glucose Intolerance 01/2021 - 01/2021
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2019 - 01/2017
2	Vasculitis (Vasculitides) 02/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 11/2022 - 10/2003
20	Biological ProductsIBA 10/2022 - 04/2011
15	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2003
10	SmokeIBA 01/2021 - 08/2003
8	P-2 (P 2)IBA 01/2017 - 09/2007
7	ORALIT (ORS)IBA 01/2021 - 05/2002
7	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 06/2006
6	Messenger RNA (mRNA)IBA 10/2020 - 10/2009
6	RNA (Ribonucleic Acid)IBA 09/2020 - 01/2015
6	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2012 - 05/2008
6	MutagensIBA 02/2011 - 12/2005
5	Estrogen ReceptorsIBA 07/2021 - 09/2008
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 09/2002
5	AutoantibodiesIBA 01/2017 - 01/2007
5	CarcinogensIBA 11/2010 - 03/2003
4	CytokinesIBA 11/2022 - 04/2015
4	Vitamin D FDA LinkGeneric 01/2022 - 03/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 09/2002
4	AntibodiesIBA 01/2019 - 11/2005
4	EnzymesIBA 11/2010 - 08/2002
4	EpitopesIBA 12/2009 - 09/2002
4	Rheumatoid FactorIBA 12/2009 - 07/2005
3	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2014
3	LigandsIBA 11/2021 - 07/2010
3	VaccinesIBA 10/2021 - 01/2017
3	Nicotine FDA Link 01/2021 - 09/2011
3	Peptides (Polypeptides)IBA 01/2018 - 12/2012
3	ParaffinIBA 10/2017 - 01/2016
3	Formaldehyde (Formol)FDA Link 10/2017 - 01/2016
3	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2017 - 10/2011
3	Amino Acids FDA Link 01/2017 - 03/2004
3	C-Reactive ProteinIBA 01/2017 - 04/2015
3	InterleukinsIBA 12/2015 - 05/2013
3	Genetic Markers (Genetic Marker)IBA 11/2015 - 07/2011
3	cyclic citrullinated peptideIBA 12/2009 - 01/2007
3	Immunoglobulin M (IgM)IBA 12/2009 - 01/2007
3	Anti-Citrullinated Protein AntibodiesIBA 05/2008 - 01/2007
3	Bleomycin (Blenoxane)FDA LinkGeneric 03/2006 - 07/2002
2	Phosphotransferases (Kinase)IBA 11/2022 - 05/2007
2	Tumor Biomarkers (Tumor Markers)IBA 10/2022 - 02/2015
2	LDL CholesterolIBA 07/2022 - 01/2017
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022 - 04/2013
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2022 - 08/2006
2	NitrosaminesIBA 01/2022 - 04/2013
2	MucinsIBA 11/2021 - 01/2019
2	LipidsIBA 01/2021 - 12/2016
2	CholesterolIBA 01/2021 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2016
2	NADP (NADPH)IBA 01/2020 - 07/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2019 - 01/2017
2	ChemokinesIBA 11/2019 - 01/2014
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2019 - 01/2017
2	AntigensIBA 01/2019 - 09/2009
2	NucleotidesIBA 11/2018 - 10/2004
2	RadonIBA 11/2018 - 05/2013

Therapy/Procedure

22	Therapeutics 12/2022 - 08/2002
9	Drug Therapy (Chemotherapy) 01/2022 - 07/2002
8	Immunotherapy 12/2022 - 02/2016
3	Cell Transplantation 01/2022 - 01/2021